Farallon Capital Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-100,000	Closed	-$2.52M	–	296
2021 Q1	$2.52M	Buy	+100,000	New	+$2.52M	0.01%	212
2017 Q2	–	Sell	-106,894	Closed	-$3.19M	–	80
2017 Q1	$3.19M	Buy	+106,894	New	+$3.19M	0.04%	66